DXRX Insider Trading

Insider Ownership Percentage: 34.30%
Insider Buying (Last 12 Months): £101,263.04
Insider Selling (Last 12 Months): £765,000

Diaceutics Insider Trading History Chart

This chart shows the insider buying and selling history at Diaceutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Diaceutics Share Price & Price History

Current Price: GBX 138
Price Change: Price Decrease of -0.5 (-0.36%)
As of 02/18/2025 08:03 AM ET

This chart shows the closing price history over time for DXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Diaceutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/30/2025Graham PatersonInsiderBuy11,643GBX 138£16,067.34
1/28/2025Jordan ClarkInsiderBuy104GBX 144£149.76
9/30/2024Nick RobertsInsiderBuy112GBX 134£150.08
8/28/2024Nick RobertsInsiderBuy113GBX 134£151.42
6/28/2024Nick RobertsInsiderBuy122GBX 1GBX 122
5/22/2024Graham PatersonInsiderBuy39,934GBX 129£51,514.86
3/28/2024Peter KeelingInsiderSell750,000GBX 102£765,000
3/6/2024Graham PatersonInsiderBuy33,564GBX 99£33,228.36
1/30/2024Nick RobertsInsiderBuy152GBX 1GBX 152
10/27/2023Nick RobertsInsiderBuy170GBX 88£149.60
8/29/2023Nick RobertsInsiderBuy139GBX 1GBX 139
6/5/2023Nick RobertsInsiderBuy21,742GBX 92£20,002.64
5/30/2023Nick RobertsInsiderBuy183GBX 82£150.06
2/28/2023Nick RobertsInsiderBuy130GBX 115£149.50
1/27/2023Nick RobertsInsiderBuy153GBX 98£149.94
12/29/2022Nick RobertsInsiderBuy198GBX 1GBX 198
10/28/2022Nick RobertsInsiderBuy181GBX 1GBX 181
9/9/2022Nick RobertsInsiderBuy161GBX 93£149.73
4/6/2022Deborah DavisInsiderBuy5,000GBX 102£5,100
See Full Table

SEC Filings (Institutional Ownership Changes) for Diaceutics (LON:DXRX)

52.38% of Diaceutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Diaceutics logo
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.
Read More on Diaceutics

Today's Range

Now: GBX 138
Low: 136.20
High: 143

50 Day Range

MA: GBX 134.53
Low: 116.50
High: 149

52 Week Range

Now: GBX 138
Low: 92.24
High: 151

Volume

128,573 shs

Average Volume

127,840 shs

Market Capitalization

£116.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of Diaceutics?

Diaceutics' top insider investors include:
  1. Graham Paterson (Insider)
  2. Jordan Clark (Insider)
  3. Nick Roberts (Insider)
  4. Peter Keeling (Insider)
Learn More about top insider investors at Diaceutics.